Secondary immune thrombocytopenia after Streptococcus infection
Hematology in Clinical Practice · 2021
DOI: 10.5603/hcp.2021.0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology in Clinical Practice, 2021. Verfasst von Katarzyna Korzeniowska und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Immune thrombocytopenia is typically characterized by a decrease in platelet (PLT) count and bleeding diathesis symptoms or increased bleeding risk. In the report, we describe a case of a 19-year-old female patient who suffered from secondary immune thrombocytopenia in the course of streptococcal pharyngitis. After diagnosis, the patient received pharmacotherapy for thrombocytopenia according to Polish standards (intravenous dexamethasone sodium phosphate) which improved the platelet level. However, the change from dexamethasone intravenous to oral prednisone resulted in PLT level decrease. Hematological improvement was observed only after changing prednisone to methylprednisolone.
Zitieren
APA
Korzeniowska, K., Cieślewicz, A., Wietlicka, I., & Jabłecka, A. (2021). Secondary immune thrombocytopenia after Streptococcus infection. Hematology in Clinical Practice. https://doi.org/10.5603/hcp.2021.0005
Vancouver
Korzeniowska K, Cieślewicz A, Wietlicka I, Jabłecka A. Secondary immune thrombocytopenia after Streptococcus infection. Hematology in Clinical Practice. 2021. doi:10.5603/hcp.2021.0005
BibTeX
@article{Korzeniowska2021,
author = {Korzeniowska, Katarzyna and Cieślewicz, Artur and Wietlicka, Irmina and Jabłecka, Anna},
title = {Secondary immune thrombocytopenia after Streptococcus infection},
journal = {Hematology in Clinical Practice},
year = {2021},
doi = {10.5603/hcp.2021.0005}
}
EUVIMED